Akihiro Ishihara
Research Subjects
Akihiro Ishihara has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Kazuhiro Maeda
Department of Orthopaedic Surgery, The Jikei University Daisan Hospital, 4-11-1 Izumihoncho, Komae, Tokyo, Japan
1 shared publication - Keishi Marumo
Orthopaedic Surgery, The Jikei University School of Medicine, Tokyo, JPN
1 shared publication - Masanori Koide
Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano, Japan
1 shared publication - Masanori Okamoto
Department of Orthopaedic Surgery Shinshu University School of Medicine Matsumoto Nagano Japan
1 shared publication - Mitsuru Saito
Department of Orthopaedic Surgery The Jikei University School of Medicine Tokyo Japan
1 shared publication - Shunsuke Uehara
Department of Biochemistry, Matsumoto Dental University
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 6 November 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (22) , 5525
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Wnt, a secreted glycoprotein, has an approximate molecular weight of 40 kDa, and it is a cytokine involved in various biological phenomena including ontogeny, morphogenesis, carcinogenesis, and maintenance of stem cells. The Wnt signaling pathway can be classified into two main pathways: canonical and non-canonical. Of these, the canonical Wnt signaling pathway promotes osteogenesis. Sclerostin produced by osteocytes is an inhibitor of this pathway, thereby inhibiting osteogenesis. Recently, osteoporosis treatment using an anti-sclerostin therapy has been introduced. In this review, the basics of Wnt signaling, its role in bone metabolism and its involvement in skeletal disorders have been covered. Furthermore, the clinical significance and future scopes of Wnt signaling in osteoporosis, osteoarthritis, rheumatoid arthritis and neoplasia are discussed.
- 6 November 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (22) , 5525
Top Cited PapersOpen AccessThe Regulation of Bone Metabolism and Disorders by Wnt Signaling
Wnt, a secreted glycoprotein, has an approximate molecular weight of 40 kDa, and it is a cytokine involved in various biological phenomena including ontogeny, morphogenesis, carcinogenesis, and maintenance of stem cells. The Wnt signaling pathway can be classified into two main pathways: canonical and non-canonical. Of these, the canonical Wnt signaling pathway promotes osteogenesis. Sclerostin produced by osteocytes is an inhibitor of this pathway, thereby inhibiting osteogenesis. Recently, osteoporosis treatment using an anti-sclerostin therapy has been introduced. In this review, the basics of Wnt signaling, its role in bone metabolism and its involvement in skeletal disorders have been covered. Furthermore, the clinical significance and future scopes of Wnt signaling in osteoporosis, osteoarthritis, rheumatoid arthritis and neoplasia are discussed.